Target intelligence / Profile preview

T cell receptor beta variable 26 (TRBV26)

Target
TRBV26
Molecular classification
Other (specifically, "T cell receptor gene segment: pseudogene")
01

Overview

TRBV26 is a gene segment in the T cell receptor beta locus, classified as a pseudogene in humans. The T cell receptor (TCR) is a protein complex on the surface of T lymphocytes responsible for recognizing peptide antigens presented by major histocompatibility complex (MHC) molecules[1][3]. Each functional TCR is a heterodimer composed of an alpha and a beta chain, both of which are assembled from gene segments (variable, diversity, joining, constant) arranged and recombined during T cell development to generate antigen specificity[1][3][4]. TRBV26 resembles functional TRBV genes but contains sequence changes resulting in a loss of protein-coding potential in humans[3]. In contrast, other TRBV segments contribute to the antigen recognition diversity of the TCR beta chain, which is essential for adaptive immunity[1][4]. As a pseudogene, TRBV26 has no direct biological or therapeutic significance. The broader class to which it belongs, T cell receptor variable gene segments, are critical for immune surveillance, infection defense, and autoimmunity[1]. If you need structured information for a functional TCR variable beta gene, please specify. For the human TRBV26 entry, current databases and expert sources agree this is a pseudogene and not a direct molecular target[3].

Other names
TCRBV26S1TCRBV28S1PTRBV26
02

Mechanism of action

Not applicable. No mechanisms of action known for drugs targeting this gene segment.

03

Biological functions

No known biological function, as it is a pseudogene in humans.Functional equivalents in other species: can serve as the variable region for the T cell receptor beta chain if not a pseudogene.
04

Disease associations

Other (No known direct disease associations because it is a pseudogene in humans.For functional TRBV genes in general: involved in immune response, autoimmunity, cancer surveillance, infection—through their role as parts of the T cell receptor)

Beyond the preview

Go deeper on T cell receptor beta variable 26 (TRBV26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 26 (TRBV26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call